Patients with CIAP who underwent TTR gene sequencing more frequently had painful polyneuropathy (42% vs. 28%, p 0.03), CTS (39% vs. 23%, p 0.03), and autonomic symptoms (59% vs. 9%, p < 0.01), compared to patients with CIAP who were not tested. This evidence concerns the gene TTR and polyneuropathy.